Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]

Detalles Bibliográficos
Autores principales: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156521/
https://www.ncbi.nlm.nih.gov/pubmed/27978996
http://dx.doi.org/10.1016/j.neo.2016.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156521/
https://www.ncbi.nlm.nih.gov/pubmed/27978996
http://dx.doi.org/10.1016/j.neo.2016.10.005

Ejemplares similares